RecruitingNot ApplicableNCT05287750
Brain Diseases on 7.0T Magnetic Resonance Imaging
Sponsor
Chinese PLA General Hospital
Enrollment
200 participants
Start Date
Jan 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
This clinical trial studies the use of 7-Tesla (7T)and 3T magnetic resonance imaging (MRI) in detecting brain diseases. 7T MRI has increased detection sensitivity, including more accurate lesion delineation, higher inter-rater agreement. Diagnostic procedures such as 7T MRI may help ultimately improved diagnostic and therapies confidence to inform decision making than standard 3T MRI.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria4
- Age≥18 and ≤80
- Having brain diseases (eg: brain tumor, cerebrovascular diseases)
- Having no contraindications against MRI or intravenous contrast agent administration
- Clinically stable
Exclusion Criteria3
- Age\<18 or \>80
- Pregnancy and other contraindication to MRI scan
- Informed consent not obtained
Interventions
DIAGNOSTIC_TESTMagnetic resonance imaging
Patients recruited will receive Magnetic resonance imaging.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05287750
Related Trials
The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
NCT062294831 location
Determining Postoperative Recovery and the Impact of Adverse Events in Neurosurgery Based on Self-reported, App-based Longitudinal Assessment
NCT063527101 location
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
NCT040334972 locations
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
NCT055881411 location
Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)
NCT058596591 location